Gamma Biosciences is an innovative life sciences platform operating a portfolio of companies focused on next-generation bioprocessing technologies to produce advanced biologic therapies. Created by KKR and other co-investors, the experts at Gamma Biosciences have years of experience building and sustaining life sciences businesses in the bioprocess, cell, and gene therapy spaces.
Visit Company Website
